EFFECT OF FORMULATION VARIABLES ON THE RELEASE OF ACECLOFENAC FROM HPMC MATRIX TABLETS

被引:0
|
作者
Mettu, S. R. [1 ]
Veerareddy, P. R. [1 ]
机构
[1] St Peters Inst Pharmaceut Sci, Dept Pharmaceut, Warangal 506001, Andhra Pradesh, India
关键词
Aceclofenac; Matrix tablets; HPMC; PEG; PVP; Solid dispersions;
D O I
10.13040/IJPSR.0975-8232.2(11).2901-07
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this work was to study the effect of concentration and viscosity grade of HPMC, different diluents and inclusion of solid dispersions on the matrix tablets of aceclofenac. In present study, aceclofenac, a novel NSAID used for symptomatic treatment of pain and inflammation was formulated into matrix tablets with HPMC of two different viscosity grades (E50 LV and K15 M) by direct compression method. Before compression the formulations were evaluated for angle of repose, % compressibility and Hausner's ratio. Tablets were evaluated for hardness, friability, weight variation, uniformity of thickness and diameter, and drug content. All pre-compressional and post-compressional parameters were found within the official limits. In vitro drug release studies were conducted for a period of 8 hrs using USP paddle method (II) at 37 +/- 0.5 degrees C and at 75rpm speed in pH 7.2 phosphate buffer. Type of polymer and its concentration has influenced the drug release from matrix tablets. With increasing concentrations and increasing polymer viscosity the release rate decreased. Release rate increased with the addition of PEG and PVP. There was significant increase in drug release by inclusion of solid dispersions in the matrix tablets. It can be concluded that by incorporating water soluble excipients such as PEG and PVP and solid dispersions of drug with PVP into the matrix, drug release can be increased. Dissolution data was analysed by Power law expression, M-t / M-infinity = kt(n). Release of drug from the tablets varied on the basis of formulation and was found to be non-Fickian and case II transport with different formulations.
引用
收藏
页码:2901 / 2907
页数:7
相关论文
共 50 条
  • [41] Influence of technological variables on the release of theophylline from hydrophilic matrix tablets
    Veiga, F
    Salsa, T
    Pina, ME
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (06) : 547 - 551
  • [42] Formulation, Characterization and In-Vitro evaluation of Aceclofenac Matrix tablets using different Polymers
    Rehman, Umaira
    Massud, Asif
    Akbar, Shehla
    Zahid, Fatima
    Abdullah, Zainab
    Kauser, Samia
    Razzaq, Asma
    Dar, Umair Ikram
    Naim, Ali
    BIOSCIENCE RESEARCH, 2022, 19 (01): : 479 - 486
  • [43] In vitro aceclofenac release from IPN matrix tablets composed of chitosan-tamarind seed polysaccharide
    Jana, Sougata
    Sen, Kalyan Kumar
    Basu, Sanat Kumar
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2014, 65 : 241 - 245
  • [44] Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets
    Viriden, Anna
    Wittgren, Bengt
    Larsson, Anette
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 36 (2-3) : 297 - 309
  • [45] FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF BACLOFEN
    Shankar, K. Ravi
    Madhan, K.
    Swetha, G.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2018, 9 (10): : 4402 - 4409
  • [46] Formulation and Evaluation of Extended Release Carbamazepine Matrix Tablets
    Manivannan, R.
    Balasubramaniam, A.
    Sandeep, G.
    Afsal, V. T. Ibrahim
    ASIAN JOURNAL OF CHEMISTRY, 2009, 21 (06) : 4737 - 4743
  • [47] Influence of enteric citric acid on the release profile of 4-aminopyridine from HPMC matrix tablets
    González, IM
    Robles, LV
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 251 (1-2) : 183 - 193
  • [48] The Impact of Dose and Solubility of Additives on the Release from HPMC Matrix Tablets-Identifying Critical Conditions
    Tajarobi, Farhad
    Abrahmsen-Alami, Susanna
    Hansen, Magnus
    Larsson, Anette
    PHARMACEUTICAL RESEARCH, 2009, 26 (06) : 1496 - 1503
  • [49] The influence of HPMC viscosity as FRC parameter on the release of low soluble drug from hydrophylic matrix tablets
    Novak, S. Devjak
    Kuhelj, V.
    Vrecer, F.
    Baumgartner, S.
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2013, 18 (02) : 343 - 347
  • [50] Identification of critical formulation and processing variables for metoprolol tartrate extended-release (ER) matrix tablets
    Rekhi, GS
    Nellore, RV
    Hussain, AS
    Tillman, LG
    Malinowski, HJ
    Augsburger, LL
    JOURNAL OF CONTROLLED RELEASE, 1999, 59 (03) : 327 - 342